Try our Advanced Search for more refined results
6,162,427
Combination of G-CSF with a chemotherapeutic agent for stem cell mobilization
- May 08, 2019 Fed. Circ. Says Sandoz Biosimilars Don't Step On Amgen IP
- August 27, 2018 Amgen Shows New Patents Can Affect Prior BPCIA Litigation
- January 13, 2017 Dance Marches On For Biosimilars In Amgen V. Sandoz
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
View all the results
Already a subscriber? Click here to login